A Phase I Study of AZD4635 in Japanese Patients with Advanced Solid Malignancies

Trial Identifier:	D8730C00005
Sponsor:	AstraZeneca
NCTID::	NCT03980821
Start Date:	July 2019
Primary Completion Date:	September 2020
Study Completion Date:	September 2020
Condition:	Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version
	Japanese Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Japan	Chuo-ku, Japan, 104-0045
Japan	Kashiwa, Japan, 277-8577

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.